The pharma innovation story isn’t resonating with vital stakeholders: prescribers and payers working in healthcare settings. Data from a global study which surveyed decision-makers in the healthcare sector reveals that only 39% of respondents in the UK saw the pharmaceutical industry as innovative.
2nd July 2019
The Court of Justice of the European Union (CJEU) has dealt a blow to innovators in two recent significant judgments, addressing questions posed by national courts struggling to judge the eligibility of SPC applications.
25th June 2019
Amanda Powel-Smith says pharma has a real opportunity to lead the way in how responsible businesses react to societal challenges
24th June 2019
Healthcare communications has always been a bit like Hogwarts. Invisible to most people, massive when you get there, and filled with magic you haven’t yet discovered. There is a creative revolution in healthcare right now.
20th June 2019
Former surgeon in training Joost Bruggeman discusses the origins of burnout in the healthcare setting and what the NHS needs to do to resolve it.
20th June 2019
Chrissie Jamieson offers her view on what pharma can do to boost brand protection amid the rise of counterfeit medicines
19th June 2019
Dr Vlado Perkovictalks to PharmaTimes about his hopes for Novo Nordisk’s FLOW trial, and the need to tackle the growing burden of chronic kidney disease (CKD) in the type II diabetes population.
3rd June 2019
Richa Munjal considers the current landscape for PCSK9 inhibitors and whether there is a brighter future on the horizon for this class of drugs.
27th May 2019
Elsevier's Maria de Kleijn-Lloyd looks at UK researchers’ contribution to the fight against melanoma
21st May 2019
With EU parliament elections fast approaching, Nick Hoile, director of Government Affairs at Publicis Resolute, considers the potential impact of a more Eurosceptic climate on health.
13th May 2019
As Mental Health Awareness Week 2019 begins (13/5/19), King’s College London Professor of Psychiatry Allan Young offers his thoughts on how a new European pharmacovigilance consortium could pave the way for new mental health drugs for UK patients.
13th May 2019
Dr Simon Hendricks, clinical strategy lead at FDB (First Databank), is excited by the recent attention from Whitehall to improving NHS prescribing. He asks what progress is already being made, what needs to happen next, and where technology can play a role.
10th May 2019
PharmaTimes talks to Jenna McDonnell, Program Manager, Project Delivery & Operational Leader for TrialConsent, at clinical research technology group CRF Bracket
8th May 2019
The rise of digital therapeutics and the shift of the health market towards payment for outcomes could be seen as a significant double threat to pharma. However, cross-industry collaboration could turn these threats into opportunities, says S3 Connected Health's Jim O’Donoghue.
8th May 2019
Compliance training should focus on promoting trust and integrity, rather than on fear of the consequences of non-compliance. Louise Vamvoukaki offers an insight into how AstraZeneca is working to ensure that its globally dispersed workforce are all living and breathing the same values and ethics.
25th April 2019
